Veerhealth Care Share Price
Sector: Biotechnology & Drugs
15.10 +0.10 (0.67%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
14.80
Today’s High
15.25
52 Week Low
9.29
52 Week High
27
Key Metrics
- Market Cap (In Cr) 30.2
- Beta 0.21
- Div. Yield (%) 0
- P/B 1.37
- TTM P/E -
- Peg Ratio -
- Sector P/E 28.32
- Open Price 14.8
- Prev Close 15
Veerhealth Care Analysis
Price Analysis
-
1 Week3.23%
-
3 Months29.2%
-
6 Month-23.47%
-
YTD-23.16%
-
1 Year-24.7%
Risk Meter
- 56% Low risk
- 56% Moderate risk
- 56% Balanced Risk
- 56% High risk
- 56% Extreme risk
Veerhealth Care Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 13.22
- Selling/ General/ Admin Expenses Total
- 1.31
- Depreciation/ Amortization
- 0.71
- Other Operating Expenses Total
- 2.17
- Total Operating Expense
- 13.33
- Operating Income
- -0.11
- Net Income Before Taxes
- 1.28
- Net Income
- 0.41
- Diluted Normalized EPS
- 0.2
- Period
- 2024
- Total Assets
- 28.12
- Total Liabilities
- 6.28
- Total Equity
- 21.84
- Tangible Book Valueper Share Common Eq
- 10.92
- Period
- 2024
- Cashfrom Operating Activities
- 2.9
- Cashfrom Investing Activities
- -0.28
- Cashfrom Financing Activities
- -5.99
- Net Changein Cash
- -3.37
- Period
- 2023
- Total Revenue
- 13.27
- Selling/ General/ Admin Expenses Total
- 0.9
- Depreciation/ Amortization
- 0.62
- Other Operating Expenses Total
- 2.64
- Total Operating Expense
- 13.4
- Operating Income
- -0.12
- Net Income Before Taxes
- 1.12
- Net Income
- 1.58
- Diluted Normalized EPS
- 0.79
- Period
- 2023
- Total Assets
- 25.25
- Total Liabilities
- 3.82
- Total Equity
- 21.43
- Tangible Book Valueper Share Common Eq
- 10.72
- Period
- 2023
- Cashfrom Operating Activities
- -0.7
- Cashfrom Investing Activities
- -1.79
- Cashfrom Financing Activities
- 5.69
- Net Changein Cash
- 3.21
- Period
- 2022
- Total Revenue
- 9.63
- Selling/ General/ Admin Expenses Total
- 0.88
- Depreciation/ Amortization
- 0.52
- Other Operating Expenses Total
- 2.65
- Total Operating Expense
- 11.06
- Operating Income
- -1.43
- Net Income Before Taxes
- 0.24
- Net Income
- -0.07
- Diluted Normalized EPS
- -0.05
- Period
- 2022
- Total Assets
- 20.15
- Total Liabilities
- 6.2
- Total Equity
- 13.95
- Tangible Book Valueper Share Common Eq
- 10.06
- Period
- 2022
- Cashfrom Operating Activities
- 1.81
- Cashfrom Investing Activities
- -1.09
- Cashfrom Financing Activities
- -0.42
- Net Changein Cash
- 0.3
- Period
- 2021
- Total Revenue
- 10.58
- Selling/ General/ Admin Expenses Total
- 0.83
- Depreciation/ Amortization
- 0.47
- Other Operating Expenses Total
- 2.17
- Total Operating Expense
- 11.2
- Operating Income
- -0.62
- Net Income Before Taxes
- 0.58
- Net Income
- 0.38
- Diluted Normalized EPS
- 0.27
- Period
- 2021
- Total Assets
- 18.73
- Total Liabilities
- 4.69
- Total Equity
- 14.04
- Tangible Book Valueper Share Common Eq
- 10.13
- Period
- 2021
- Cashfrom Operating Activities
- 1
- Cashfrom Investing Activities
- -0.09
- Cashfrom Financing Activities
- -0.83
- Net Changein Cash
- 0.09
- Period
- 2020
- Total Revenue
- 11.73
- Selling/ General/ Admin Expenses Total
- 0.8
- Depreciation/ Amortization
- 0.32
- Other Operating Expenses Total
- 2.37
- Total Operating Expense
- 11.56
- Operating Income
- 0.17
- Net Income Before Taxes
- 0.65
- Net Income
- 0.32
- Diluted Normalized EPS
- 0.23
- Period
- 2020
- Total Assets
- 17.98
- Total Liabilities
- 4.23
- Total Equity
- 13.76
- Tangible Book Valueper Share Common Eq
- 9.92
- Period
- 2020
- Cashfrom Operating Activities
- -0.36
- Cashfrom Investing Activities
- -1.67
- Cashfrom Financing Activities
- 1.85
- Net Changein Cash
- -0.17
- Period
- 2019
- Total Revenue
- 5.98
- Selling/ General/ Admin Expenses Total
- 0.47
- Depreciation/ Amortization
- 0.32
- Other Operating Expenses Total
- 1.28
- Total Operating Expense
- 5.9
- Operating Income
- 0.09
- Net Income Before Taxes
- 0.38
- Net Income
- 0.16
- Diluted Normalized EPS
- 0.11
- Period
- 2019
- Total Assets
- 16.16
- Total Liabilities
- 2.88
- Total Equity
- 13.28
- Tangible Book Valueper Share Common Eq
- 9.58
- Period
- 2019
- Cashfrom Operating Activities
- 1.98
- Cashfrom Investing Activities
- -1.9
- Cashfrom Financing Activities
- 0.02
- Net Changein Cash
- 0.1
- Period
- 2024-12-31
- Total Revenue
- 3.84
- Selling/ General/ Admin Expenses Total
- 0.53
- Depreciation/ Amortization
- 0.25
- Other Operating Expenses Total
- 0.51
- Total Operating Expense
- 3.95
- Operating Income
- -0.11
- Net Income Before Taxes
- 0.07
- Net Income
- 0.07
- Diluted Normalized EPS
- 0.04
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 5.15
- Selling/ General/ Admin Expenses Total
- 0.39
- Depreciation/ Amortization
- 0.2
- Other Operating Expenses Total
- 1.3
- Total Operating Expense
- 4.98
- Operating Income
- 0.17
- Net Income Before Taxes
- 0.42
- Net Income
- 0.3
- Diluted Normalized EPS
- 0.15
- Period
- 2024-09-30
- Total Assets
- 30.97
- Total Liabilities
- 8.71
- Total Equity
- 22.26
- Tangible Book Valueper Share Common Eq
- 11.13
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 3.46
- Cashfrom Investing Activities
- -3.1
- Cashfrom Financing Activities
- -0.11
- Net Changein Cash
- 0.25
- Period
- 2024-06-30
- Total Revenue
- 2.06
- Selling/ General/ Admin Expenses Total
- 0.32
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.48
- Total Operating Expense
- 2.27
- Operating Income
- -0.21
- Net Income Before Taxes
- 0.15
- Net Income
- 0.12
- Diluted Normalized EPS
- 0.06
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 2.94
- Selling/ General/ Admin Expenses Total
- 0.44
- Depreciation/ Amortization
- 0.18
- Other Operating Expenses Total
- 0.4
- Total Operating Expense
- 3.34
- Operating Income
- -0.4
- Net Income Before Taxes
- 0.19
- Net Income
- -0.52
- Diluted Normalized EPS
- -0.29
- Period
- 2024-03-31
- Total Assets
- 28.12
- Total Liabilities
- 6.28
- Total Equity
- 21.84
- Tangible Book Valueper Share Common Eq
- 10.92
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 2.9
- Cashfrom Investing Activities
- -0.28
- Cashfrom Financing Activities
- -5.99
- Net Changein Cash
- -3.37
- Period
- 2023-12-31
- Total Revenue
- 2.87
- Selling/ General/ Admin Expenses Total
- 0.29
- Depreciation/ Amortization
- 0.18
- Other Operating Expenses Total
- 0.46
- Total Operating Expense
- 2.87
- Operating Income
- 0
- Net Income Before Taxes
- 0.24
- Net Income
- 0.19
- Diluted Normalized EPS
- 0.09
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Veerhealth Care Technical
Moving Average
SMA
- 5 Day14.99
- 10 Day14.22
- 20 Day13.33
- 50 Day13.55
- 100 Day15.4
- 300 Day18.32
Veerhealth Care Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Gujarat Inject Kerala
- 25.31
- -1.33
- -4.99
- 29.12
- 13.11
- 37.13
- Concord Drugs
- 32
- 0.53
- 1.68
- 44.96
- 26.1
- 32
- Veerhealth Care
- 15.1
- 0.1
- 0.67
- 27
- 9.29
- 30.2
- Vineet Laboratories
- 31
- 0
- 0
- 78.48
- 25.35
- 28.58
- Fone4 Communications (india)
- 11.39
- 0
- 0
- 19.25
- 3.78
- 19.42
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Gujarat Inject Kerala
- 40.06
- 3.17
- 9.82
- 4.14
- Concord Drugs
- 66.68
- 0.93
- 4.8
- 2.58
- Veerhealth Care
- 73.82
- 1.37
- 3.23
- 4.47
- Vineet Laboratories
- -
- 1.99
- -6.99
- -1.09
- Fone4 Communications (india)
- -
- 2.78
- -
- -
Veerhealth Care Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 30-May-25
- Audited Results & Final Dividend
- 12-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 14-Aug-24
- Quarterly Results & Others
- 30-May-24
- Audited Results & Final Dividend
- 20-Feb-24
- Others
- 10-Feb-24
- Quarterly Results & Others
- 08-Nov-23
- Quarterly Results
- 25-Sept-23
- Allotment of Equity shares
- 14-Aug-23
- Quarterly Results, Bonus issue & A.G.M.
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 29-Aug-24
- AGM
- 11-Sept-23
- 16-Aug-23
- AGM

- Announced on
- Record Date
- Ex-Bonus
- Description
- 14-Aug-23
- 22-Sept-23
- 22-Sept-23
- Bonus issue in the ratio of 1:1 of Rs. 10/-.

